Research

Researchers have revealed the mechanisms involved in the progression of cancer cells, opening new therapeutic perspectives against pancreatic cancer. In observing cancer cells in patients […]

Joan Massagué, 70, says that a great change is taking place in science’s ongoing battle against cancer. New research into metastasis has led to a leap

Scientists say they have identified a ‘kill switch’ that triggers the death of cancer cells in a major breakthrough. Researchers at the UC Davis Comprehensive Cancer Center in

Almost 300,000 women are to be offered a drug to reduce their risk of developing breast cancer, NHS officials have announced. Some 289,000 post-menopausal women

(ANSA) – ROME, NOV 1 – A team of Italian scientists have found one of the engines that drive cancer of the pancreas, one of

Cancer often takes its time before it triggers first warning signs, meaning it’s often picked up at a later stage. However, the sooner the cancer

Biotechnology company ABM Therapeutics has dosed the first patient in its Phase I study to evaluate ABM-1310 in patients with relapsed and drug-resistant primary malignant

On 24 August, Exelixis announced the early suspension of the double-blinded Phase III CABINET pivotal trial evaluating Exelixis’s Cabometyx (cabozantinib) for patients with progressive, well-differentiated

Researchers from the Wellcome-MRC Cambridge Stem Cell Institute (CSCI), the University of Cambridge’s Department of Haematology and the Instituto de Investigación Sanitaria del Principado de

Anew Israeli study could open the door to more efficient treatment of certain types of lung cancer, and the prevention of a relapse of illness.

Researchers at City of Hope, one of the largest cancer research and treatment organisations in the US, are developing a chimeric antigen receptor (CAR) T

Scientists have stumbled upon an extraordinary ‘living drug‘ in the bloodwork of a late-stage cancer survivor. A year after receiving “the biggest development in cancer therapy” in